全基因组测序预测淋病奈瑟菌抗菌药物敏感性谱
研究对2004至2019年来自5个国家的481株淋病奈瑟菌分离株(构成457个独特基因组)进行琼脂稀释法药敏试验和全基因组测序,评估基因位点预测抗菌药物敏感性的能力。结果显示所有环丙沙星敏感株(MIC≤0.06 μg/mL)均具有野生型gyrA第91位密码子,预测其他抗菌药物敏感性需多位点方法,所有分离株对zoliflodacin敏感(MIC≤0.25 μg/mL)。
要点
- 所有环丙沙星敏感株(MIC≤0.06 μg/mL)均具有野生型gyrA第91位密码子。
- 预测其他抗菌药物敏感性需采用多位点分子标记方法。
- 全部481株分离株对zoliflodacin敏感(MIC≤0.25 μg/mL)。
核心结论
- 单标记预测可用于指导淋病奈瑟菌感染的环丙沙星治疗。
- 确定其他抗菌药物的敏感性可能需要联合分子标记。
研究设计与样本
- 研究纳入2004至2019年来自5个国家的481株淋病奈瑟菌分离株,构成457个独特基因组。
- 采用琼脂稀释法测定常用抗菌药物及zoliflodacin的最低抑菌浓度(MIC)。
- 从全基因组测序数据中识别已知耐药位点的耐药等位基因,并测试各 locus 预测抗菌药物敏感性的能力。
主要发现
- 所有对环丙沙星敏感的分离株(MIC≤0.06 μg/mL)均具有野生型gyrA第91位密码子。
- 预测其他抗菌药物的敏感性需要多位点方法。
- 所有分离株均对zoliflodacin敏感,定义为MIC≤0.25 μg/mL。
关键数值与推荐
- 环丙沙星敏感定义为MIC≤0.06 μg/mL,对应野生型gyrA第91位密码子。
- zoliflodacin敏感定义为MIC≤0.25 μg/mL。
临床怎么用
- 单标记预测可用于指导淋病奈瑟菌感染的环丙沙星治疗。
- 其他抗菌药物的敏感性判断可能需要联合分子标记。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Neisseria gonorrhoeae is a major public health problem due to increasing incidence and antimicrobial resistance. Genetic markers of reduced susceptibility have been identified; the extent to which those are representative of global antimicrobial resistance is unknown. We evaluated the performance of whole-genome sequencing (WGS) used to predict susceptibility to ciprofloxacin and other antimicrobials using a global collection of N. gonorrhoeae isolates. METHODS: Susceptibility testing of common antimicrobials and the recently developed zolifodacin was performed using agar dilution to determine minimum inhibitory concentrations (MICs). We identified resistance alleles at loci known to contribute to antimicrobial resistance in N. gonorrhoeae from WGS data. We tested the ability of each locus to predict antimicrobial susceptibility. RESULTS: A total of 481 N. gonorrhoeae isolates, collected between 2004 and 2019 and making up 457 unique genomes, were sourced from 5 countries. All isolates with demonstrated susceptibility to ciprofloxacin (MIC ≤0.06 μg/mL) had a wild-type gyrA codon 91. Multilocus approaches were needed to predict susceptibility to other antimicrobials. All isolates were susceptible to zoliflodacin, defined by an MIC ≤0.25 μg/mL. CONCLUSIONS: Single marker prediction can be used to inform ciprofloxacin treatment of N. gonorrhoeae infection. A combination of molecular markers may be needed to determine susceptibility for other antimicrobials.
引用
- Bristow CC, Mortimer TD, Morris S, et al. Whole-Genome Sequencing to Predict Antimicrobial Susceptibility Profiles in Neisseria gonorrhoeae. J Infect Dis. 2023. PMID: 36735316. doi:10.1093/infdis/jiad027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。